Skip to main content

Rutinib

Ruxolitinib is a JAK inhibitor that acts primarily on JAK1 and JAK2. These enzymes transmit signals from a number of cytokines and growth factors involved in immune activity, inflammation and blood-cell production.

Rutinib.com presents three ruxolitinib products:

  1. Rutinib Cream
  2. Rutinib 5 mg
  3. Ruxotor 10 mg

About Rutinib Cream

Rutinib Cream is the topical member of the Rutinib product family. Topical ruxolitinib is applied directly to affected skin rather than swallowed.

The established U.S. reference product in this category is OPZELURA, a ruxolitinib cream. Current U.S. labeling identifies it as a JAK inhibitor for specified atopic dermatitis and nonsegmental vitiligo indications.

About Rutinib 5 mg

Rutinib 5 mg is identified as an oral ruxolitinib product with a stated 5 mg strength.

Oral ruxolitinib is pharmacologically different from topical application because the medicine is administered systemically. Oral ruxolitinib products have indications including selected myelofibrosis, polycythemia vera and graft-versus-host disease settings depending on the applicable regulatory authorization.

About Ruxotor 10 mg

Ruxotor 10 mg is identified as an oral ruxolitinib product with a stated 10 mg strength.

The 10 mg strength should not be interpreted as a universal treatment dose. Oral ruxolitinib dosing can depend on platelet count, disease, treatment response, adverse reactions, renal function, hepatic function and interacting medicines.

How the Three Products Differ

CharacteristicRutinib CreamRutinib 5 mgRuxotor 10 mg
Active substanceRuxolitinibRuxolitinibRuxolitinib
RouteTopicalOralOral
Main treatment contextSkin disordersSystemic diseasesSystemic diseases
Dose conceptApplied to skinIndividualized oral regimenIndividualized oral regimen
ExposurePrimarily related to topical administrationSystemicSystemic
Regulatory labelTopical-specificOral-specificProduct/jurisdiction-specific

The products should never be treated as interchangeable simply because they contain the same active ingredient.